Literature DB >> 16251783

Neurosyphilis in a tertiary care hospital in north India.

Sunil Sethi1, Anindita Das, Neerja Kakkar, S S Banga, S Prabhakar, Meera Sharma.   

Abstract

BACKGROUND AND OBJECTIVES: The clinical diagnosis of neurosyphilis is very rarely encountered today in the developed world although syphilis remains a significant health problem in few areas of the industrialized countries and in most of the third world nations. This apparent decline may be due to increase in number of asymptomatic neurosyphilis and cases presenting as subtle, illdefined syndromes rather than classic presentation of tabes dorsalis and general paresis in the post penicillin era. This retrospective study was carried out to report the neurosyphilis cases diagnosed at a tertiary care hospital in North India, and to analyse the laboratory and clinical parameters of these cases.
METHODS: Suspected cases of neurosyphilis presenting at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh over a period of 13 yr (January 1990 to December 2002) were identified. Diagnosis of neurosyphilis was based on clinical presentation, prior history of syphilis, routine CSF biochemistry (protein and leukocytes) and serological evidence [serum and CSF venereal disease research laboratory (VDRL) and Treponema pallidum particle agglutination (TPPA) tests].
RESULTS: A total of 25 cases of neurosyphilis were identified, 18 (72%) with reactive CSF-VDRL, 22 (88%) with elevated CSF protein and 24 (96%) with CSF mononuclear leukocytosis. Serum VDRL was reactive in all 25 cases. Three patients were asymptomatic (2 primary syphilis; 1 early latent stage), 8 had secondary and 14 had tertiary syphilis. Two of the neurosyphilis cases were also seropositive for HIV. Radiology was abnormal in 7 (28%) patients. INTERPRETATION AND
CONCLUSION: Neurosyphilis still remains a problem in a country like India and a high index of suspicion and clinical expertise are required for appropriate diagnosis and proper management especially in the era of AIDS pandemic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251783

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  8 in total

1.  Valproate for treatment of agitation in neurosyphilis: a case report.

Authors:  Prashant Tibrewal; Indu Kumar; Amit Zutshi; Suresh Bada Math
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

2.  Rising trends of syphilis in a tertiary care center in North India.

Authors:  Sunil Sethi; Abhishek Mewara; Vinaykumar Hallur; Amber Prasad; Kusum Sharma; Atul Raj
Journal:  Indian J Sex Transm Dis AIDS       Date:  2015 Jul-Dec

3.  Differential diagnosis of white matter diseases in the tropics: An overview.

Authors:  Lekha Pandit
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

4.  Neurosyphilis in the age of AIDS: clinical and laboratory features.

Authors:  Lívia Leite Góes Gitaí; Paulo Samandar Jaláli; Osvaldo Massaiti Takayanagui
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

5.  General paresis of insane: A rarity or reality?

Authors:  Suravi Patra; Ajaya Mishra
Journal:  Ind Psychiatry J       Date:  2010-07

6.  Erb's paraplegia with primary optic atrophy: Unusual presentation of neurosyphilis: Case report and review of literature.

Authors:  Chandramohan Sharma; Kunal Nath; Banshi Lal Kumawat; Dinesh Khandelwal; Deepak Jain
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

Review 7.  Medullary involvement in neurosyphilis: a report of 12 cases and a review of the literature.

Authors:  Hafida Elmouden; Nisserine Louhab; Najib Kissani
Journal:  Spinal Cord Ser Cases       Date:  2019-05-01

8.  Neurosyphilis, A True Chameleon of Neurology.

Authors:  Shripad S Pujari; Rahul V Kulkarni; Dhananjay Duberkar; Satish Nirhale; Dattatraya Nadgir; Pramod Dhonde; Tejas Sakale; Prafulla Shembalkar; Chandrashekhar Meshram
Journal:  Ann Indian Acad Neurol       Date:  2021-06-17       Impact factor: 1.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.